LEQEMBI now set to launch in Japan for Alzheimer’s disease
TOKYO: Swedish firm BioArctic AB’s partner Eisai has announced that LEQEMBI (lecanemab) will be launched
TOKYO: Swedish firm BioArctic AB’s partner Eisai has announced that LEQEMBI (lecanemab) will be launched
FEATURED
Operator opens new homes for seniors in regional city
Best affordable seniors housing design for Global Awards shortlisted
Bank to support housing for seniors and people with disability
Multigenerational housing makes comeback as market conditions improve
New research confirms dementia growth in all generations
Boomer turned 1000 straw bales into a fortress-like house
INNOVATION
